Fertilo In Vitro Research Study and Trial

Part of paid clinical trials in Clovis, California.

Sponsor
Gameto, Inc.
Study ID
NCT06858111
Phase
PHASE3
Status
Recruiting

Conditions

  • In Vitro Maturation of Oocytes

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 35 Years
Healthy Volunteers
Accepted

Interventions

  • Fertilo — BIOLOGICAL
    Fertilo is an engineered line of ovarian support cells that aid egg maturation.
  • Medicult IVM — DEVICE
    MediCult IVM is a system of culture media designed for the in vitro maturation of immature oocytes.

Study Details

The goal of this clinical trial is to evaluate the safety and efficacy of using Fertilo for In vitro maturation (IVM) in participants 18-35 years of age. The main question it aims to answer is whether the use of Fertilo is superior to using Medicult IVM for In vitro maturation. Researchers will compare the number of ongoing pregnancies at 12 weeks gestation for participants in each arm. * Arm 1 participants will have all cumulus oocyte complexes (COCs), or eggs surrounded by helper cells, cultured in Fertilo for 30 hours. * Arm 2 participants will have all cumulus oocyte complexes (COCs), or eggs surrounded by helper cells, cultured in Medicult IVM for 30 hours.

Key Dates

Start date
Apr 17, 2025
Status verified
Jun 2026
Primary completion
May 31, 2027
Completion
Jan 31, 2028

Study Design

Enrollment
500 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Fertilo
    Immature cumulus-oocyte complexes (COCs) are oocytes surrounded by cumulus cells that have not yet matured. The COCs are cultured in Fertilo coculture condition then fertilized, grown to the blastocyst stage, vitrified, and later transferred for reproductive purpose.
  • Active Comparator: Medicult IVM®
    Immature COCs are cultured in the standard IVM system MediCult IVM® then fertilized, grown to the blastocyst stage, vitrified, and later transferred for reproductive purpose.

Primary Outcome Measure

Demonstration of the superiority of Fertilo compared to the currently approved MediCult IVM® for infertility treatment via IVF procedures. [ Time Frame: 12 weeks gestation ]

Central Contacts

Locations (13)

FacilityCityStateZIPSite coordinators
Women's Specialty & Fertility CenterClovisCalifornia93611
Casey Study Coordinator
559-299-7700
Carlos Sueldo, MD (PRINCIPAL_INVESTIGATOR)
HRC FertilityEncinoCalifornia91436
Wendy Shubin, MPAS, PA-C
818-788-7288
Robert Boostanfar, MD (PRINCIPAL_INVESTIGATOR)
Florida Fertility InstituteClearwaterFlorida33759
Gayle Cameron
727-724-9730
Mark Sanchez, MD (PRINCIPAL_INVESTIGATOR)
IVF FloridaPembroke PinesFlorida33026
Karina Stroker
954-247-6200
Luis Hoyos, MD (PRINCIPAL_INVESTIGATOR)
Shady Grove FertilityRockvilleMaryland20850
Joshua McKeeby
301-545-1423
Kate Devine, MD (PRINCIPAL_INVESTIGATOR)
Columbia University Fertility CenterNew YorkNew York10019
Stephanie Morgan
212-314-8837
Eric Forman, MD (PRINCIPAL_INVESTIGATOR)
Reach FertilityCharlotteNorth Carolina28207
Stephanie Graham, MS
704-343-4455
Jack Crain, MD (PRINCIPAL_INVESTIGATOR)
Conceptions FertilityRaleighNorth Carolina27607
Sofia Sequeira
919-782-5911
John Park, MD (PRINCIPAL_INVESTIGATOR)
Care FertilityBedfordTexas76022
Michelle Evans
817-540-7070
Charlene Nwajei
Kevin Doody, MD (PRINCIPAL_INVESTIGATOR)
Dallas Fort Worth Fertility AssociatesDallasTexas75231
Jenny Patel
214-363-5965
Samuel Chantilis, MD (PRINCIPAL_INVESTIGATOR)
Aspire Fertility San AntonioSan AntonioTexas78528
Sonam Study Coordinator
575-815-8206
Jennifer Knudtson, MD (PRINCIPAL_INVESTIGATOR)
Shady Grove HoustonWebsterTexas77598
Cara Barrier, RN
832-342-9129
Maryanne Fisher, RN
281-557-3084
Vicki Schnell, MD (PRINCIPAL_INVESTIGATOR)
Utah Fertility CenterPleasant GroveUtah84062
Coral Halterman, RN
801-785-5100
Shawn Gurtcheff, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Clovis, CA